Prosecuted For Truthful Off-Label Promotion: Part 2
The interplay of off-label use of drugs and medical devices, manufacturer statements about off-label use, the First Amendment, and U.S. Food and Drug Administration enforcement is complex. The disconnect between the FDA's...To view the full article, register now.
Already a subscriber? Click here to view full article